Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers
In the version of this article initially published, due to a version error, values listed on the right-hand side of Fig. 1 were incorrect, where
Authors
- Doenja M. J. Lambregts (ORCID: https://orcid.org/0000-0003-2990-0099)
- Roelof Koster (ORCID: https://orcid.org/0000-0003-1424-8579)
- Hilde H. Nienhuis (ORCID: https://orcid.org/0009-0003-6016-7814)
- Paul Roepman (ORCID: https://orcid.org/0000-0003-1566-0258)
- Tom van Wezel (ORCID: https://orcid.org/0000-0001-5773-7730)
- Efraim H. Rosenberg (ORCID: https://orcid.org/0000-0002-3859-6941)
- Linda J.W. Bosch (ORCID: https://orcid.org/0000-0001-6323-9316)
- Kim Monkhorst (ORCID: https://orcid.org/0000-0002-8690-3811)
- Marieke A. Vollebergh (ORCID: https://orcid.org/0000-0002-6524-3068)
- Edwin Cuppen (ORCID: https://orcid.org/0000-0002-0400-9542)
- Joseph Usset (ORCID: https://orcid.org/0000-0002-5820-9881)
- Mirjam C. Boelens
- Serena Marchetti (ORCID: https://orcid.org/0000-0001-6783-0584)
- Petur Snaebjornsson
- Jeffrey van Putten
- Lizet E. van der Kolk
Institutions
- University of Iceland (IS)
- Dutch Cancer Society (NL)
- Leiden University Medical Center (NL)
- The Netherlands Cancer Institute (NL)
- University Medical Center Utrecht (NL)
- Oncode Institute (NL)
- Hartwig Medical Foundation (NL)
Publication Details
- Journal
- Nature Medicine
- Published
- 2026-04-01
- DOI
- https://doi.org/10.1038/s41591-026-04379-6
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00